Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Sibbing

Showing results (31-40 of 200) with videos related to

Pageof 20
Sort By:
JACC. Cardiovascular Interventions|June 12, 2024
Spoiled for Choice: P2Y<sub>12</sub> Receptor Inhibition in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDirk Sibbing, Steffen Massberg, Konstantinos D Rizas
Current Drug Targets|July 2, 2011
Role of platelet function testing in clinical practice: current concepts and future perspectivesDirk Sibbing, Robert A Byrne, Adnan Kastrati
Current Pharmaceutical Design|June 26, 2012
Clinical use of clopidogrelNikolaus Sarafoff, Robert A Byrne, Dirk Sibbing
Thrombosis and Haemostasis|June 9, 2017
Antithrombotic therapy for acute coronary syndrome: Past, present and futureDirk Sibbing, Dominick J Angiolillo, Kurt Huber
Current Vascular Pharmacology|February 21, 2012
In the bivalirudin era, are we still looking for a potent antiplatelet agent?Bernardo Cortese, Antonino Pitì, Adnan Kastrati, et al.
Cardiology|November 7, 2013
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyondVictor L Serebruany, Dirk Sibbing, James J DiNicolantonio
JACC. Cardiovascular Interventions|August 24, 2013
Bleeding and thrombosis risk matters: how long can we stick to the one-size-fits-all strategy of platelet inhibition?Dirk Sibbing, Lisa Gross, Martin Orban, et al.
Thrombosis and Haemostasis|June 12, 2019
Risk Evaluation Tools for Prediction and Possible Guidance of DAPT: Is Scoring a Hit in East Asians Patients undergoing PCI?Ralph Hein, Freek W A Verheugt, Dirk Sibbing
European Heart Journal|September 15, 2020
The ESC Working Group on ThrombosisGemma Vilahur, Bianca Rocca, Andrea Rubboli, et al.
Journal of Thoracic Disease|January 15, 2021
Effect of genotype-guided strategy in East Asian <i>vs.</i> Caucasian patients after percutaneous coronary intervention: insight from the TAILOR-PCI trialHyun Kuk Kim, Dirk Sibbing, Young-Hoon Jeong
Pageof 20

Showing results (31-40 of 200) with videos related to

Sort By:
Pageof 20
JACC. Cardiovascular Interventions|June 12, 2024
Spoiled for Choice: P2Y<sub>12</sub> Receptor Inhibition in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary InterventionDirk Sibbing, Steffen Massberg, Konstantinos D Rizas
Current Drug Targets|July 2, 2011
Role of platelet function testing in clinical practice: current concepts and future perspectivesDirk Sibbing, Robert A Byrne, Adnan Kastrati
Current Pharmaceutical Design|June 26, 2012
Clinical use of clopidogrelNikolaus Sarafoff, Robert A Byrne, Dirk Sibbing
Thrombosis and Haemostasis|June 9, 2017
Antithrombotic therapy for acute coronary syndrome: Past, present and futureDirk Sibbing, Dominick J Angiolillo, Kurt Huber
Current Vascular Pharmacology|February 21, 2012
In the bivalirudin era, are we still looking for a potent antiplatelet agent?Bernardo Cortese, Antonino Pitì, Adnan Kastrati, et al.
Cardiology|November 7, 2013
Dyspnea and reversibility of antiplatelet agents: ticagrelor, elinogrel, cangrelor, and beyondVictor L Serebruany, Dirk Sibbing, James J DiNicolantonio
JACC. Cardiovascular Interventions|August 24, 2013
Bleeding and thrombosis risk matters: how long can we stick to the one-size-fits-all strategy of platelet inhibition?Dirk Sibbing, Lisa Gross, Martin Orban, et al.
Thrombosis and Haemostasis|June 12, 2019
Risk Evaluation Tools for Prediction and Possible Guidance of DAPT: Is Scoring a Hit in East Asians Patients undergoing PCI?Ralph Hein, Freek W A Verheugt, Dirk Sibbing
European Heart Journal|September 15, 2020
The ESC Working Group on ThrombosisGemma Vilahur, Bianca Rocca, Andrea Rubboli, et al.
Journal of Thoracic Disease|January 15, 2021
Effect of genotype-guided strategy in East Asian <i>vs.</i> Caucasian patients after percutaneous coronary intervention: insight from the TAILOR-PCI trialHyun Kuk Kim, Dirk Sibbing, Young-Hoon Jeong
Pageof 20